Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001144204-18-044701

← back to feed
Filed
Aug 14, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Aug 14, 2018 20M sh
Cash And Equivalents Q1 2019 · Jun 30, 2018 $75.86K
Cash And Equivalents Q1 2019 · Mar 31, 2018 $92.88K
Cash And Equivalents Q1 2019 · Jun 30, 2017 $67.17K
Cash And Equivalents Q1 2019 · Mar 31, 2017 $147.11K
Stockholders Equity Q1 2019 · Jun 30, 2018 $3.09M
Stockholders Equity Q1 2019 · Mar 31, 2018 $3.23M
Current Liabilities Q1 2019 · Jun 30, 2018 $2.11M
Current Liabilities Q1 2019 · Mar 31, 2018 $2.13M
Current Assets Q1 2019 · Jun 30, 2018 $1.5M
Current Assets Q1 2019 · Mar 31, 2018 $1.67M
Total Assets Q1 2019 · Jun 30, 2018 $5.28M
Total Assets Q1 2019 · Mar 31, 2018 $5.44M
Shares Diluted Q1 2019 · Jun 30, 2017 20M sh
Operating Cash Flow Q1 2019 · Jun 30, 2017 −$33.52K
Eps Diluted Q1 2019 · Jun 30, 2017 $0.00
Eps Basic Q1 2019 · Jun 30, 2017 $0.00
Sga Expense Q1 2019 · Jun 30, 2017 $185.51K
Rd Expense Q1 2019 · Jun 30, 2017 $1.64K
Net Income Q1 2019 · Jun 30, 2017 $62.43K
Operating Income Q1 2019 · Jun 30, 2017 $7.23K
Gross Profit Q1 2019 · Jun 30, 2017 $458.17K
Cost Of Revenue Q1 2019 · Jun 30, 2017 $333.17K
Revenue Q1 2019 · Jun 30, 2017 $791.34K